Molecular Templates (MTEM)
(Delayed Data from NSDQ)
$1.71 USD
+0.11 (6.56%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $1.74 +0.04 (2.05%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for Molecular Templates Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 12 | 61 | 143 | 94 | 125 |
Receivables | 0 | 0 | 0 | 0 | 8 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 5 | 7 | 5 | 7 | 7 |
Total Current Assets | 17 | 68 | 148 | 101 | 140 |
Net Property & Equipment | 7 | 15 | 19 | 22 | 18 |
Investments & Advances | 0 | 0 | 9 | 0 | 2 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 2 | 3 | 7 | 5 | 5 |
Total Assets | 35 | 98 | 192 | 140 | 174 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 1 | 2 | 2 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 4 | 9 | 10 | 13 | 15 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 12 | 48 | 36 | 23 | 20 |
Total Current Liabilities | 17 | 57 | 47 | 38 | 36 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 6 | 33 | 8 | 19 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 36 | 35 | 15 | 3 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 1 | 2 | 8 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 31 | 113 | 127 | 81 | 71 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 457 | 430 | 418 | 328 | 267 |
Retained Earnings | -453 | -445 | -352 | -269 | -164 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 4 | -15 | 66 | 59 | 103 |
Total Liabilities & Shareholder's Equity | 35 | 98 | 192 | 140 | 174 |
Total Common Equity | 4 | -15 | 66 | 59 | 103 |
Shares Outstanding | 5.30 | 3.70 | 3.70 | 3.30 | 2.40 |
Book Value Per Share | 0.79 | -4.09 | 17.75 | 17.98 | 42.93 |
Fiscal Year End for Molecular Templates Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 12 | 16 | 5 | 42 |
Receivables | NA | 0 | 0 | 0 | 3 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 5 | 7 | 7 | 7 |
Total Current Assets | NA | 17 | 23 | 12 | 52 |
Net Property & Equipment | NA | 7 | 9 | 10 | 13 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 2 | 3 | 3 | 3 |
Total Assets | NA | 35 | 44 | 36 | 79 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 3 | 5 | 3 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 4 | 3 | 4 | 6 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 12 | 16 | 19 | 22 |
Total Current Liabilities | NA | 17 | 22 | 27 | 30 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 1 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 36 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 5 | 6 | 1 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 31 | 37 | 44 | 80 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 457 | 456 | 436 | 432 |
Retained Earnings | NA | -453 | -449 | -445 | -434 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 4 | 7 | -9 | -2 |
Total Liabilities & Shareholder's Equity | NA | 35 | 44 | 36 | 79 |
Total Common Equity | 0 | 4 | 7 | -9 | -2 |
Shares Outstanding | 5.30 | 5.30 | 5.30 | 3.70 | 3.70 |
Book Value Per Share | 0.00 | 0.79 | 1.28 | -2.35 | -0.52 |